Flagstaff, AZNCT07404865Now EnrollingIRB Ready

Primary Sjogren's Disease Clinical Trial in Flagstaff, AZ

Access cutting-edge primary sjogren's disease treatment through this clinical trial at a research site in Flagstaff. Study-provided care at no cost to qualified participants.

Sponsored by Vor Biopharma

Quick Self-Assessment

See if you qualify for this Flagstaff location

Preparing your pre-screening questions…

Expert Care in Flagstaff

Access primary sjogren's disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary sjogren's disease treatment provided free

Apply for This Flagstaff Location

Check if you qualify for this primary sjogren's disease clinical trial in Flagstaff, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Flagstaff

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Flagstaff site if eligible
  4. 4Begin participation

About This Primary Sjogren's Disease Study in Flagstaff

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

Sponsor: Vor Biopharma

Who Can Participate

Inclusion Criteria

Male or female aged 18 to 75 years of age (both inclusive) at screening
Participants must meet the 2016 American College of Rheumatology (ACR)/EULAR classification criteria for primary Sjogren's Syndrome at the time of screening.
ESSDAI ≥5 at screening (score calculated excluding renal, pulmonary and neurological domains)
Participants are seropositive for antibodies to Sjogren's Syndrome A (SSA)/Anti-Sjogren's Syndrome A (Ro) at the Screening Visit. Additional inclusion criteria are defined in the protocol

Exclusion Criteria

Participants who have a systemic autoimmune disease other than Primary Sjogren's Disease, such as rheumatoid arthritis, systemic lupus erythematosus, or systemic sclerosis, that can better explain the majority of the symptoms (i.e., secondary Sjogren's Disease)
Participants who have another autoimmune disease or inflammatory condition that could interfere with assessment of response of Primary Sjogren's Disease to therapy (e.g., systemic sclerosis, inflammatory bowel disease, gout).
Participants with severe fibromyalgia that could interfere with the assessment of response of Primary Sjogren's Disease to therapy
Active life-threatening or organ-threatening complications of Primary Sjogren's Disease at the time of screening based on investigator evaluation
Significant, uncontrolled medical disease in any organ system not related to Primary Sjogren's Disease (e.g., poorly controlled asthma, cardiovascular disease, accelerated hypertension, major depression, etc.) that in the opinion of the investigator would preclude participant participation. Additional exclusion criteria are defined in the protocol

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Flagstaff?

Yes, this clinical trial (NCT07404865) has an active research site in Flagstaff, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Sjogren's Disease Treatment Options in Flagstaff, AZ

If you're searching for primary sjogren's disease treatment options in Flagstaff, AZ, this clinical trial (NCT07404865) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Flagstaff research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary sjogren's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary sjogren's disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Flagstaff, AZ

See all ankylosing spondylitis clinical trials recruiting in Flagstaff — not just this study.

Browse Ankylosing Spondylitis Trials in Flagstaff →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsSjogrens Syndrome TrialsAll Conditions →

Ready to Join in Flagstaff?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Flagstaff, AZ